Our current engagements offer a glimpse of the depth and breadth of the services we offer, and the results we deliver.
Markman Advisors provides an ongoing subscription service to institutional investors, family offices and individual investors for consulting on pending patent litigations affecting public companies. Stocks currently/previously covered include life-sciences (CELG, CBST, AUXL, DEPO, ACT, JAZZ, ENZ, TEVA, MNTA, MYGN), high-tech (PANW, CRDS, CALL, OTIV, GOOG, AAPL) and patent-monetization companies (VRNG, VHC, PRKR, FNJN, WDDD, MARA, SITO, SPEX, UPIP, PPRO), among others. Contact us for further details on our consulting offerings for investors.
Markman Advisors provides ongoing strategic advice and guidance to investors interested in implementing trading strategies based on patent litigation event-driven situations. Contact us for further details on our consulting offerings for event-driven funds.
Markman Advisors develops and launches Litigation Alpha, a subscription-based service that provides near-real-time alerts of patent litigation events as they occur. Visit www.litigationalpha.com for more information.
Markman Advisors is currently working on behalf of inventors to monetize existing patent portfolios, including providing patent brokering, litigation analysis, and investment procuring services. Contact us for further details on our patent monetization offerings for inventors.
Markman Advisors is currently working with a number of private and publicly-traded companies on the development and implementation of patent monetization strategies. Contact us for further details on our patent monetization offerings for companies.
Publications & Presentations
Markman Advisors has published extensively on the interplay between patent activities and public company valuations, and has led a symposium on the topic in conjunction with Prof. Dan Ravicher of Cardozo Law School in New York City. See here for a list of our articles.